1. Home
  2. LEXX vs AMST Comparison

LEXX vs AMST Comparison

Compare LEXX & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

BUY

Current Price

$2.86

Market Cap

6.7M

Sector

Health Care

ML Signal

BUY

Logo Amesite Inc.

AMST

Amesite Inc.

BUY

Current Price

$0.84

Market Cap

6.1M

Sector

Technology

ML Signal

BUY

Company Overview

Basic Information
Metric
LEXX
AMST
Founded
2004
N/A
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.7M
6.1M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
LEXX
AMST
Price
$2.86
$0.84
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
72.9K
★ 76.8K
Earning Date
11-27-2026
10-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 38.83
EPS
★ N/A
N/A
Revenue
★ $705,923.00
$364,777.00
Revenue This Year
N/A
$19,089.81
Revenue Next Year
$6,915.00
$22.86
P/E Ratio
★ N/A
N/A
Revenue Growth
52.05
★ 230.24
52 Week Low
$0.35
$0.77
52 Week High
$21.60
$3.90

Technical Indicators

Market Signals
Indicator
LEXX
AMST
Relative Strength Index (RSI) 35.35 30.63
Support Level $2.79 $0.77
Resistance Level $12.98 $1.11
Average True Range (ATR) 0.42 0.05
MACD 0.20 -0.02
Stochastic Oscillator 11.57 10.10

Price Performance

Historical Comparison
LEXX
AMST

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

About AMST Amesite Inc.

Amesite Inc is a technology company focused on building and commercializing AI (artificial intelligence)-powered solutions for the enterprise and for professionals, with particular emphasis on the post-acute healthcare market. It operates through two product lines: NurseMagic and LynkMagic. NurseMagic solutions include a B2B (business-to-business) enterprise application and a B2C (business-to-consumer) solution for individual healthcare professionals. LynkMagic provides enterprise AI solutions for healthcare and related organizations. Its products support documentation, workflow, compliance, oversight, and are designed to improve operational quality and efficiency. It has one single operating and reporting segment, B2C and B2B AI-driven solutions.

Share on Social Networks: